{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:27:58Z","timestamp":1790771278409,"version":"4.1.0"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.neuropharm.2021.108910","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T11:23:10Z","timestamp":1638789790000},"page":"108910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["CNS pharmacology of NKCC1 inhibitors"],"prefix":"10.1016","volume":"205","author":[{"given":"Wolfgang","family":"L\u00f6scher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Kaila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108910_bib1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1369\/jhc.2010.956045","article-title":"The detailed localization pattern of Na+\/K+\/2Cl- cotransporter type 2 and its related ion transport system in the rat endolymphatic sac","volume":"58","author":"Akiyama","year":"2010","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/epi.16790","article-title":"A\u00a0physiologically-validated rat model of term birth asphyxia with seizure generation after, not during, brain hypoxia","volume":"62","author":"Ala-Kurikka","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.conb.2005.08.006","article-title":"Signaling between glia and neurons: focus on synaptic plasticity","volume":"15","author":"Allen","year":"2005","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000339050","article-title":"Expression of the Slc12a1 gene in pancreatic beta-cells: molecular characterization and in silico analysis","volume":"30","author":"Alshahrani","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/14756366.2017.1405263","article-title":"Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor","volume":"33","author":"Alterio","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib6","series-title":"Cell Physiology Sourcebook","first-page":"221","article-title":"Intracellular chloride regulation","author":"Alvarez-Leefmans","year":"2012"},{"key":"10.1016\/j.neuropharm.2021.108910_bib7","doi-asserted-by":"crossref","first-page":"107422","DOI":"10.1016\/j.pharmthera.2019.107422","article-title":"Impaired chloride homeostasis in epilepsy: molecular basis, impact on treatment, and current treatment approaches","volume":"205","author":"Auer","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2021.108910_bib8","doi-asserted-by":"crossref","first-page":"107754","DOI":"10.1016\/j.neuropharm.2019.107754","article-title":"Functional characterization of novel bumetanide derivatives for epilepsy treatment","volume":"162","author":"Auer","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108910_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/joim.12645","article-title":"Vasopressin: physiology, assessment and osmosensation","volume":"282","author":"Bankir","year":"2017","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.neuropharm.2021.108910_bib10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1528-1167.2011.03247.x","article-title":"Positive shifts of the GABAA receptor reversal potential due to altered chloride homeostasis is widespread after status epilepticus","volume":"52","author":"Barmashenko","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1113\/jphysiol.1989.sp017762","article-title":"Giant synaptic potentials in immature rat CA3 hippocampal neurones","volume":"416","author":"Ben Ari","year":"1989","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1152\/physrev.00017.2006","article-title":"GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations","volume":"87","author":"Ben Ari","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108910_bib13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tins.2017.07.001","article-title":"NKCC1 chloride importer antagonists attenuate many neurological and psychiatric disorders","volume":"40","author":"Ben Ari","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib14","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050145","article-title":"Carbonic anhydrase seven bundles filamentous actin and regulates dendritic spine morphology and density","volume":"22","author":"Bertling","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neuropharm.2021.108910_bib15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2009.03.003","article-title":"Cation-chloride cotransporters and neuronal function","volume":"61","author":"Blaesse","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108910_bib16","doi-asserted-by":"crossref","first-page":"10203","DOI":"10.1021\/acs.jmedchem.1c00603","article-title":"Design, synthesis, in vitro and in vivo characterization of selective NKCC1 inhibitors for the treatment of core symptoms in down syndrome","volume":"64","author":"Borgogno","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib17","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1523\/JNEUROSCI.0633-10.2010","article-title":"Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy","volume":"30","author":"Brandt","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuropharm.2018.09.025","article-title":"Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy","volume":"143","author":"Brandt","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108910_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/35051086","article-title":"Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance","volume":"409","author":"Brickley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108910_bib20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1176\/appi.ajp.161.5.889","article-title":"Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring","volume":"161","author":"Brown","year":"2004","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108910_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by organic anion transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2021.108910_bib22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/13543776.2013.780598","article-title":"Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2","volume":"23","author":"Carta","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.neuropharm.2021.108910_bib23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.immuni.2017.06.008","article-title":"Mechanisms and therapeutic relevance of neuro-immune communication","volume":"46","author":"Chavan","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.neuropharm.2021.108910_bib24","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1471-4159.2007.04638.x","article-title":"AMPA-mediated excitotoxicity in oligodendrocytes: role for Na(+)-K(+)-Cl(-) co-transport and reversal of Na(+)\/Ca(2+) exchanger","volume":"102","author":"Chen","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00010.2003","article-title":"Regulation and modulation of pH in the brain","volume":"83","author":"Chesler","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108910_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-019-1438-2","article-title":"Structure and mechanism of the cation-chloride cotransporter NKCC1","volume":"572","author":"Chew","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108910_bib27","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020107294","article-title":"Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters","volume":"40","author":"Chi","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2021.108910_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/48a011e6-e4d0-4706-9a28-857eba8cfb31","article-title":"Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures","volume":"8","author":"Cleary","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2021.108910_bib29","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1126\/science.1076510","article-title":"On the origin of interictal activity in human temporal lobe epilepsy in\u00a0vitro","volume":"298","author":"Cohen","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2021.108910_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/j.1552-4604.1981.tb05662.x","article-title":"Pharmacology of bumetanide","volume":"21","author":"Cohen","year":"1981","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3565(25)30556-2","article-title":"A\u00a0comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog","volume":"197","author":"Cohen","year":"1976","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108910_bib32","doi-asserted-by":"crossref","first-page":"E1618","DOI":"10.1073\/pnas.1716871115","article-title":"Restoring GABAergic inhibition rescues memory deficits in a Huntington's disease mouse model","volume":"115","author":"Dargaei","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2021.108910_bib33","article-title":"The role of cytokines in the pathogenesis of schizophrenia","volume":"10","author":"Dawidowski","year":"2021","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.neuropharm.2021.108910_bib34","doi-asserted-by":"crossref","first-page":"11811","DOI":"10.1074\/jbc.M213148200","article-title":"Identification of a functionally important conformation-sensitive region of the secretory Na+-K+-2Cl- cotransporter (NKCC1)","volume":"278","author":"Dehaye","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nm.3827","article-title":"Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome","volume":"21","author":"Deidda","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108910_bib36","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/j.2040-4603.2018.tb00016.x","article-title":"Na(+) -K(+) -2Cl(-) cotransporter (NKCC) physiological function in nonpolarized cells and transporting epithelia","volume":"8","author":"Delpire","year":"2018","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib37","doi-asserted-by":"crossref","first-page":"C522","DOI":"10.1152\/ajpcell.00490.2018","article-title":"Elusive role of the Na-K-2Cl cotransporter in the choroid plexus","volume":"316","author":"Delpire","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib38","doi-asserted-by":"crossref","first-page":"C324","DOI":"10.1152\/ajpcell.00566.2020","article-title":"Advances in the development of novel compounds targeting cation-chloride cotransporter physiology","volume":"320","author":"Delpire","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib39","first-page":"145","article-title":"Ototoxic effects and mechanisms of loop diuretics","volume":"11","author":"Ding","year":"2016","journal-title":"J.\u00a0Otolaryngol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.conb.2010.12.006","article-title":"Molecular signals of plasticity at the tetrapartite synapse","volume":"21","author":"Dityatev","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fphar.2015.00041","article-title":"G\u00a0protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease","volume":"6","author":"Divorty","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/WCO.0b013e328337f451","article-title":"Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments","volume":"23","author":"Donkin","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/jphp.12341","article-title":"The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in\u00a0vivo microdialysis study in the rat","volume":"67","author":"Donovan","year":"2015","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2015.12.001","article-title":"In\u00a0vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanide","volume":"770","author":"Donovan","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib45","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nm1301","article-title":"NKCC1 transporter facilitates seizures in the developing brain","volume":"11","author":"Dzhala","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108910_bib46","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/epi.13346","article-title":"The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice","volume":"57","author":"Erker","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1021\/jm00287a014","article-title":"Aminobenzoic acid diuretics. 2. 4-Substituted-3-amino-5-sulfamylbenzoic acid derivatives","volume":"14","author":"Feit","year":"1971","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/j.1552-4604.1981.tb05661.x","article-title":"Bumetanide--the way to its chemical structure","volume":"21","author":"Feit","year":"1981","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib49","series-title":"Camforth","first-page":"1","article-title":"Bumetanide: historical background, taxonomy and chemistry","author":"Feit","year":"1990"},{"key":"10.1016\/j.neuropharm.2021.108910_bib50","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1124\/pr.119.018762","article-title":"Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease","volume":"72","author":"Felmlee","year":"2020","journal-title":"Pharmacol. Rev."},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2021.108910_bib51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1469-7793.1999.0699s.x","article-title":"Regulation of Na+-K+-2Cl- cotransport by protein phosphorylation in ferret erythrocytes","volume":"517","author":"Flatman","year":"1999","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib52","doi-asserted-by":"crossref","first-page":"11787","DOI":"10.1016\/S0021-9258(17)44299-2","article-title":"[3H]bumetanide binding to membranes isolated from dog kidney outer medulla. Relationship to the Na,K,Cl co-transport system","volume":"258","author":"Forbush","year":"1983","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib53","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0028-3908(79)90108-4","article-title":"Influence of inhibitors of the high affinity GABA uptake on seizures thresholds in mice","volume":"18","author":"Frey","year":"1979","journal-title":"Neuropharmacology"},{"issue":"Suppl. 6","key":"10.1016\/j.neuropharm.2021.108910_bib1a","first-page":"14","article-title":"Pharmacology of bumetanide","volume":"61","author":"Frey","year":"1979","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.neuropharm.2021.108910_bib54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0028-3908(80)90141-0","article-title":"Cetyl GABA: effect of convulsant thresholds in mice and acute toxicity","volume":"19","author":"Frey","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108910_bib55","first-page":"F1","article-title":"Sodium-coupled chloride transport by epithelial tissues","volume":"236","author":"Frizzell","year":"1979","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib56","series-title":"Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications","author":"Frost","year":"2014"},{"key":"10.1016\/j.neuropharm.2021.108910_bib57","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1248\/bpb.b17-00076","article-title":"Functional expression of organic ion transporters in astrocytes and their potential as a drug target in the treatment of central nervous system diseases","volume":"40","author":"Furihata","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2021.108910_bib58","doi-asserted-by":"crossref","first-page":"C693","DOI":"10.1152\/ajpcell.00350.2012","article-title":"Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts","volume":"304","author":"Gagnon","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib59","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/nm.3356","article-title":"Chloride extrusion enhancers as novel therapeutics for neurological diseases","volume":"19","author":"Gagnon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108910_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/adt.2017.787","article-title":"A\u00a0high-throughput screening assay for NKCC1 cotransporter using nonradioactive rubidium flux technology","volume":"15","author":"Gill","year":"2017","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib61","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.tins.2017.03.006","article-title":"Chloride dysregulation, seizures, and cerebral edema: a relationship with therapeutic potential","volume":"40","author":"Glykys","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib62","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fnins.2020.00514","article-title":"Chronic bumetanide infusion alters young neuron morphology in the dentate gyrus without affecting contextual fear memory","volume":"14","author":"G\u00f3mez-Correa","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib64","doi-asserted-by":"crossref","first-page":"C525","DOI":"10.1152\/ajpcell.00026.2018","article-title":"Genetic and pharmacological inactivation of apical Na(+)-K(+)-2Cl(-) cotransporter 1 in choroid plexus epithelial cells reveals the physiological function of the cotransporter","volume":"316","author":"Gregoriades","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib65","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1038\/ncomms10715","article-title":"The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis","volume":"7","author":"Gumireddy","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108910_bib67","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1152\/jn.00944.2004","article-title":"Furosemide and mannitol suppression of epileptic activity in the human brain","volume":"94","author":"Haglund","year":"2005","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0090-9556(25)06303-2","article-title":"A\u00a0relationship between the metabolism of bumetanide and its diuretic activity in the rat","volume":"6","author":"Halladay","year":"1978","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2021.108910_bib69","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1038\/s41598-018-27995-w","article-title":"Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B","volume":"8","author":"Hampel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2021.108910_bib70","series-title":"The Search for Brain-Permeant NKCC1 Inhibitors for the Treatment of Seizures: Pharmacokinetic-Pharmacodynamic Modelling of NKCC1 Inhibition by Azosemide, Torasemide, and Bumetanide in Mouse Brain","first-page":"107616","author":"Hampel","year":"2021"},{"key":"10.1016\/j.neuropharm.2021.108910_bib71","series-title":"Effects of the NKCC1 Inhibitors Bumetanide, Azosemide, and Torasemide Alone or in Combination with Phenobarbital on Seizure Threshold in Epileptic and Nonepileptic Mice","author":"Hampel","year":"2021"},{"key":"10.1016\/j.neuropharm.2021.108910_bib72","doi-asserted-by":"crossref","first-page":"105297","DOI":"10.1016\/j.nbd.2021.105297","article-title":"Deletion of the Na-K-2Cl cotransporter NKCC1 results in a more severe epileptic phenotype in the intrahippocampal kainate mouse model of temporal lobe epilepsy","volume":"152","author":"Hampel","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2021.108910_bib73","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00210-001-0521-y","article-title":"Rat NKCC2\/NKCC1 cotransporter selectivity for loop diuretic drugs","volume":"365","author":"Hannaert","year":"2002","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib75","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1124\/jpet.103.059139","article-title":"Interactions of human organic anion transporters with diuretics","volume":"308","author":"Hasannejad","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108910_bib76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.2005090966","article-title":"Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide","volume":"18","author":"Hasegawa","year":"2007","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib77","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.neuron.2020.08.030","article-title":"LTP induction boosts glutamate spillover by driving withdrawal of perisynaptic Astroglia","volume":"108","author":"Henneberger","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108910_bib78","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.1136","article-title":"Are certain diuretics also anticonvulsants?","volume":"50","author":"Hesdorffer","year":"2001","journal-title":"Ann. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2021.108910_bib2a","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1528-1167.2012.03471.x","article-title":"The extracellular space and epileptic activity in the adult brain: explaining the antiepileptic effects of furosemide and bumetanide","volume":"53","author":"Hochman","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib79","series-title":"American Epilepsy Society 63th Annual Meeting Abstracts Online Abst. 3.035","article-title":"Evidence that bumetanide suppresses epileptiform activity in adult primate cortex independent of effects on GABA-A signalling","author":"Hochman","year":"2009"},{"key":"10.1016\/j.neuropharm.2021.108910_bib80","series-title":"Methods and Compositions for the Treatment of Neuropsychiatric Disorders with Bumetanide and Furosemide Analogs","author":"Hochman","year":"2006"},{"key":"10.1016\/j.neuropharm.2021.108910_bib81","series-title":"Methods and Compositions Using NKCC Cotransporter Inhibitors for the Treatment of Neuropsychiatric and Addictive Disorders","author":"Hochman","year":"2007"},{"key":"10.1016\/j.neuropharm.2021.108910_bib82","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nn.4113","article-title":"Neuroimmune mechanisms of depression","volume":"18","author":"Hodes","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib83","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.psyneuen.2014.04.004","article-title":"Differences in HPA-axis and heart rate responsiveness to psychosocial stress in children with autism spectrum disorders with and without co-morbid anxiety","volume":"46","author":"Hollocks","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2021.108910_bib84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yebeh.2017.10.025","article-title":"Seizure-induced activation of the HPA axis increases seizure frequency and comorbid depression-like behaviors","volume":"78","author":"Hooper","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2021.108910_bib87","doi-asserted-by":"crossref","first-page":"626","DOI":"10.14336\/AD.2018.0928","article-title":"The WNK-SPAK\/OSR1 kinases and the cation-chloride cotransporters as therapeutic targets for neurological diseases","volume":"10","author":"Huang","year":"2019","journal-title":"Aging Dis"},{"key":"10.1016\/j.neuropharm.2021.108910_bib88","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/STROKEAHA.118.024287","article-title":"A\u00a0novel Na(+)-K(+)-Cl(-) cotransporter 1 inhibitor STS66\u2217 reduces brain damage in mice after ischemic stroke","volume":"50","author":"Huang","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2021.108910_bib89","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainresbull.2017.02.011","article-title":"The role of aquaporin-4 in synaptic plasticity, memory and disease","volume":"136","author":"Hubbard","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2021.108910_bib90","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1523\/JNEUROSCI.2761-07.2007","article-title":"Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy","volume":"27","author":"Huberfeld","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib91","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/jm2010332","article-title":"Rational approaches to improving selectivity in drug design","volume":"55","author":"Huggins","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib92","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bcp.2018.08.013","article-title":"Bumetanide attenuates acute lung injury by suppressing macrophage activation","volume":"156","author":"Hung","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib93","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0896-6273(01)00297-5","article-title":"Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition","volume":"30","author":"H\u00fcbner","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2021.108910_bib94","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0925-4773(01)00309-4","article-title":"Expression of the Na-K-2Cl-cotransporter NKCC1 during mouse development","volume":"102","author":"H\u00fcbner","year":"2001","journal-title":"Mech. Dev."},{"key":"10.1016\/j.neuropharm.2021.108910_bib95","series-title":"Vascularmechanisms in CNS Trauma, Springer Series in Translational Stroke Research, 5","first-page":"29","article-title":"Mechanisms of cerebral edema leading to early seizures after traumatic brain injury","author":"Iffland","year":"2014"},{"key":"10.1016\/j.neuropharm.2021.108910_bib96","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(89)90688-2","article-title":"Intracerebroventricular injection of ethacrynic acid induces status epilepticus","volume":"166","author":"Inoue","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib97","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1073\/pnas.95.12.7179","article-title":"The role of transmembrane domain 2 in cation transport by the Na-K-Cl cotransporter","volume":"95","author":"Isenring","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2021.108910_bib98","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1085\/jgp.112.5.549","article-title":"Mutagenic mapping of the Na-K-Cl cotransporter for domains involved in ion transport and bumetanide binding","volume":"112","author":"Isenring","year":"1998","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib99","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/WCO.0000000000000710","article-title":"What are neurodevelopmental disorders?","volume":"32","author":"Ismail","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib100","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1471-4159.1993.tb13648.x","article-title":"Ionic composition of cisternal CSF in acute respiratory acidosis: lack of effect of large dose bumetanide","volume":"61","author":"Javaheri","year":"1993","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib101","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1152\/physrev.1995.75.4.689","article-title":"Nonsynaptic modulation of neuronal activity in the brain: electric currents and extracellular ions","volume":"75","author":"Jefferys","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108910_bib102","doi-asserted-by":"crossref","first-page":"106869","DOI":"10.1016\/j.vascn.2020.106869","article-title":"A\u00a0practical guide to secondary pharmacology in drug discovery","volume":"105","author":"Jenkinson","year":"2020","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.neuropharm.2021.108910_bib104","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/epi.16778","article-title":"Phenobarbital and midazolam suppress neonatal seizures in a non-invasive rat model of birth asphyxia while bumetanide is ineffective","volume":"62","author":"Johne","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib103","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/epi.16912","article-title":"A\u00a0combination of phenobarbital and the bumetanide derivative bumepamine prevents neonatal seizures and subsequent hippocampal neurodegeneration in a rat model of birth asphyxia","volume":"62","author":"Johne","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib105","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ncpneuro0883","article-title":"Roles of the cation-chloride cotransporters in neurological disease","volume":"4","author":"Kahle","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib106","first-page":"257","article-title":"Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport","volume":"24","author":"Kahle","year":"2009","journal-title":"Physiology. (Bethesda. )"},{"key":"10.1016\/j.neuropharm.2021.108910_bib107","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tins.2013.08.006","article-title":"Modulation of neuronal activity by phosphorylation of the K-Cl cotransporter KCC2","volume":"36","author":"Kahle","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib108","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamaneurol.2014.21","article-title":"Therapeutic restoration of spinal inhibition via druggable enhancement of potassium-chloride cotransporter KCC2-mediated chloride extrusion in peripheral neuropathic pain","volume":"71","author":"Kahle","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib109","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0301-0082(94)90049-3","article-title":"Ionic basis of GABAA receptor channel function in the nervous system","volume":"42","author":"Kaila","year":"1994","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrn3819","article-title":"Cation-chloride cotransporters in neuronal development, plasticity and disease","volume":"15","author":"Kaila","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib111","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.conb.2013.11.004","article-title":"GABA actions and ionic plasticity in epilepsy","volume":"26","author":"Kaila","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib112","series-title":"Jasper's Basic Mechanisms of the Epilepsies","article-title":"GABAA-receptor signaling and ionic plasticity in the generation and spread of seizures","author":"Kaila","year":"2022"},{"key":"10.1016\/j.neuropharm.2021.108910_bib113","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.anl.2008.04.012","article-title":"Expression of aquaporin1, 3, and 4, NKCC1, and NKCC2 in the human endolymphatic sac","volume":"36","author":"Kakigi","year":"2009","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.neuropharm.2021.108910_bib114","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fncel.2015.00173","article-title":"Age- and sex-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters","volume":"9","author":"Kang","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib115","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/nm.4361","article-title":"Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus","volume":"23","author":"Karimy","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108910_bib116","doi-asserted-by":"crossref","first-page":"107979","DOI":"10.1016\/j.celrep.2020.107979","article-title":"Lysophosphatidic acid-mediated GPR35 signaling in CX3CR1(+) macrophages regulates intestinal homeostasis","volume":"32","author":"Kaya","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108910_bib117","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/dneu.22634","article-title":"Pharmaco-resistant neonatal seizures: critical mechanistic insights from a chemoconvulsant model","volume":"78","author":"Kharod","year":"2018","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib118","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnins.2019.00310","article-title":"Off-label use of bumetanide for brain disorders: an overview","volume":"13","author":"Kharod","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib121","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/bph.14125","article-title":"Bumetanide blocks the acquisition of conditioned fear in adult rats","volume":"175","author":"Ko","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib122","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2005.09.054","article-title":"Mouse organic anion transporter 2 and 3 (mOAT2\/3[Slc22a7\/8]) mediates the renal transport of bumetanide","volume":"524","author":"Kobayashi","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib123","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0026-895X(25)08539-6","article-title":"Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor","volume":"47","author":"Korpi","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib124","first-page":"zqaa028","volume":"vol. 2","author":"Koumangoye","year":"2021"},{"key":"10.1016\/j.neuropharm.2021.108910_bib125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.24870","article-title":"Depolarizing gamma-aminobutyric acid contributes to glutamatergic network rewiring in epilepsy","volume":"81","author":"Kourdougli","year":"2017","journal-title":"Ann. Neurol."},{"issue":"Pt 6","key":"10.1016\/j.neuropharm.2021.108910_bib126","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/brain\/121.6.1073","article-title":"Spontaneous sharp waves in human neocortical slices excised from epileptic patients","volume":"121","author":"K\u00f6hling","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2021.108910_bib127","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41598-017-01814-0","article-title":"The neuronal K(+)Cl(-) co-transporter 2 (Slc12a5) modulates insulin secretion","volume":"7","author":"Kursan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2021.108910_bib128","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.addr.2004.07.007","article-title":"Efflux transport systems for organic anions and cations at the blood-CSF barrier","volume":"56","author":"Kusuhara","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuropharm.2021.108910_bib129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1602\/neurorx.2.1.73","article-title":"Active efflux across the blood-brain barrier: role of the solute carrier family","volume":"2","author":"Kusuhara","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuropharm.2021.108910_bib130","doi-asserted-by":"crossref","first-page":"772278","DOI":"10.3389\/fnagi.2021.772278","article-title":"Carbonic anhydrases as potential targets against neurovascular unit dysfunction in Alzheimer's disease and stroke","volume":"13","author":"Lemon","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib131","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/j.1651-2227.2010.01933.x","article-title":"The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects","volume":"99","author":"Lemonnier","year":"2010","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.neuropharm.2021.108910_bib132","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.124","article-title":"A\u00a0randomised controlled trial of bumetanide in the treatment of autism in children","volume":"2","author":"Lemonnier","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108910_bib133","article-title":"Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders","volume":"7","author":"Lemonnier","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108910_bib135","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jchromb.2011.02.018","article-title":"Sensitive isotope dilution liquid chromatography\/tandem mass spectrometry method for quantitative analysis of bumetanide in serum and brain tissue","volume":"879","author":"Li","year":"2011","journal-title":"J\u00a0Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib136","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-3565(25)21841-9","article-title":"High anticonvulsant potency of y-aminobutyric acid(GABA)mimetic drugs in gerbils with genetically determined epilepsy","volume":"226","author":"L\u00f6scher","year":"1983","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108910_bib137","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-2999(85)90034-2","article-title":"Anticonvulsant action in the epileptic gerbil of novel inhibitors of GABA uptake","volume":"110","author":"L\u00f6scher","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib138","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2021.108910_bib139","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"Suppl.\u00a08","key":"10.1016\/j.neuropharm.2021.108910_bib140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12025","article-title":"How theories evolved concerning the mechanism of action of barbiturates","volume":"53","author":"L\u00f6scher","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib141","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2012.05.045","article-title":"Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments","volume":"69","author":"L\u00f6scher","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108910_bib142","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/ijms21020591","article-title":"Structural, molecular and functional alterations of the blood-brain barrier during epileptogenesis and epilepsy: a cause, consequence or both?","volume":"21","author":"L\u00f6scher","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib143","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/epi.16866","article-title":"Bumetanide and neonatal seizures: fiction vs. reality","volume":"62","author":"L\u00f6scher","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib144","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2006.07.048","article-title":"Inhibition of the Na+ -K+ -2Cl- -cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage","volume":"548","author":"Lu","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib145","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/CCM.0B013E31816590C4","article-title":"NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf\/MEK\/MAPK cascade","volume":"36","author":"Lu","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.neuropharm.2021.108910_bib146","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3389\/fphys.2020.00911","article-title":"Role of NKCC1 activity in glioma K(+) homeostasis and cell growth: new insights with the bumetanide-derivative STS66","volume":"11","author":"Luo","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib147","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1111\/bph.13231","article-title":"Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of human NKCC2 variant A","volume":"172","author":"Lykke","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib148","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yebeh.2016.03.021","article-title":"The search for NKCC1-selective drugs for the treatment of epilepsy: structure-function relationship of bumetanide and various bumetanide derivatives in inhibiting the human cation-chloride cotransporter NKCC1A","volume":"59","author":"Lykke","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2021.108910_bib150","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.neuropharm.2015.07.035","article-title":"The emerging pharmacology and function of GPR35 in the nervous system","volume":"113","author":"Mackenzie","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108910_bib151","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.yebeh.2012.09.040","article-title":"Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy","volume":"26","author":"Maguire","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2021.108910_bib152","series-title":"Neuronal Chloride Transporters in Health and Disease","first-page":"1","article-title":"A\u00a0historical overview of chloride transporter research","author":"Mahadevan","year":"2020"},{"key":"10.1016\/j.neuropharm.2021.108910_bib153","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrn1949","article-title":"Variability, compensation and homeostasis in neuron and network function","volume":"7","author":"Marder","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib154","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/nm.3987","article-title":"Treatment during a vulnerable developmental period rescues a genetic epilepsy","volume":"21","author":"Marguet","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2021.108910_bib155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00424-013-1370-5","article-title":"Physiology and pathophysiology of SLC12A1\/2 transporters","volume":"466","author":"Markadieu","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2021.108910_bib156","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cbpa.2010.06.166","article-title":"Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks","volume":"14","author":"Metz","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib157","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1124\/mol.108.053744","article-title":"Inhibition of aquaporin-1 and aquaporin-4 water permeability by a derivative of the loop diuretic bumetanide acting at an internal pore-occluding binding site","volume":"76","author":"Migliati","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib158","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12028-010-9376-8","article-title":"Na(+)-K (+)-2Cl (-) cotransport inhibitor attenuates cerebral edema following experimental stroke via the perivascular pool of aquaporin-4","volume":"13","author":"Migliati","year":"2010","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.neuropharm.2021.108910_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npp.2016.229","article-title":"The immunology of behavior-exploring the role of the immune system in brain health and illness","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2021.108910_bib161","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00424-013-1342-9","article-title":"Ion transporters in brain endothelial cells that contribute to formation of brain interstitial fluid","volume":"466","author":"Mokgokong","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2021.108910_bib162","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1124\/dmd.105.005264","article-title":"Functional characterization of human monocarboxylate transporter 6 (SLC16A5)","volume":"33","author":"Murakami","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuropharm.2021.108910_bib163","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1430","article-title":"GABAergic interneurons excite neonatal hippocampus in\u00a0vivo","volume":"6","author":"Murata","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2021.108910_bib164","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s004240051095","article-title":"Chloride channel blockers attenuate the inhibition of renin secretion by angiotensin II","volume":"438","author":"Nabel","year":"1999","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2021.108910_bib165","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.20061205","article-title":"Mice lacking NKCC1 are protected from development of bacteremia and hypothermic sepsis secondary to bacterial pneumonia","volume":"204","author":"Nguyen","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.neuropharm.2021.108910_bib166","first-page":"12","article-title":"Structure-activity relationships of aminobenzoic acid diuretics and related compounds","volume":"83","author":"Nielsen","year":"1978"},{"key":"10.1016\/j.neuropharm.2021.108910_bib167","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1080\/00016480802441754","article-title":"Expression of aquaporins, vasopressin type 2 receptor, and Na+(-)K+(-)Cl(-) cotransporters in the rat endolymphatic sac","volume":"129","author":"Nishimura","year":"2009","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib168","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92801","article-title":"A\u00a0salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage","volume":"2","author":"Norlander","year":"2017","journal-title":"JCI. Insight."},{"key":"10.1016\/j.neuropharm.2021.108910_bib169","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eplepsyres.2013.10.013","article-title":"Seizure-induced disinhibition of the HPA axis increases seizure susceptibility","volume":"108","author":"O'Toole","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108910_bib170","first-page":"17","volume":"vol. 13","author":"Oh","year":"2015"},{"key":"10.1016\/j.neuropharm.2021.108910_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0773.1977.tb03209.x","article-title":"The pharmacology of bumetanide","volume":"41","author":"Olsen","year":"1977","journal-title":"Acta Pharmacol. Toxicol. (Copenh)"},{"key":"10.1016\/j.neuropharm.2021.108910_bib172","doi-asserted-by":"crossref","first-page":"C139","DOI":"10.1152\/ajpcell.1980.238.3.C139","article-title":"cAMP-stimulated cation cotransport in avian erythrocytes: inhibition by \"loop\" diuretics","volume":"238","author":"Palfrey","year":"1980","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib173","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcp.10055","article-title":"Na(+)\/K(+)\/Cl(-) cotransporter activates mitogen-activated protein kinase in fibroblasts and lymphocytes","volume":"190","author":"Panet","year":"2002","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib174","series-title":"BUMETANIDE ANALOGS, COMPOSITIONS and METHODS of USE. United States Patent US 9","author":"Pardridge","year":"2017"},{"key":"10.1016\/j.neuropharm.2021.108910_bib175","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1146\/annurev-immunol-042617-053158","article-title":"Molecular and functional neuroscience in immunity","volume":"36","author":"Pavlov","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib176","doi-asserted-by":"crossref","first-page":"17977","DOI":"10.1074\/jbc.270.30.17977","article-title":"Primary structure, functional expression, and chromosomal localization of the bumetanide-sensitive Na-K-Cl cotransporter in human colon","volume":"270","author":"Payne","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib177","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1038\/s41598-017-04264-w","article-title":"Predicting the reliability of drug-target interaction predictions with maximum coverage of target space","volume":"7","author":"Pe\u00f3n","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2021.108910_bib178","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/s41556-019-0431-1","article-title":"Interpreting an apoptotic corpse as anti-inflammatory involves a chloride sensing pathway","volume":"21","author":"Perry","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib179","doi-asserted-by":"crossref","first-page":"e13467","DOI":"10.1111\/apha.13467","article-title":"Endogenous bain-sparing responses in brain pH and PO2 in a rodent model of birth asphyxia","volume":"229","author":"Pospelov","year":"2020","journal-title":"Acta Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib180","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/epi.16963","article-title":"Carbonic anhydrase inhibitors suppress seizures in a rat model of birth asphyxia","volume":"62","author":"Pospelov","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib181","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib182","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/epi.12620","article-title":"Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures","volume":"55","author":"Puskarjov","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib183","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1021\/acsptsci.0c00079","article-title":"Therapeutic opportunities and challenges in targeting the Orphan G protein-coupled receptor GPR35","volume":"3","author":"Quon","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib184","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/neu.2010.1705","article-title":"Aquaporin-4 expression in cultured astrocytes after fluid percussion injury","volume":"28","author":"Rao","year":"2011","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.neuropharm.2021.108910_bib185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fdata.2019.00025","article-title":"Novel computational approach to predict off-target interactions for small molecules","volume":"2","author":"Rao","year":"2019","journal-title":"Front Big. Data"},{"key":"10.1016\/j.neuropharm.2021.108910_bib186","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1208\/s12248-008-9009-8","article-title":"Prodrug approaches for CNS delivery","volume":"10","author":"Rautio","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.neuropharm.2021.108910_bib187","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejps.2017.08.002","article-title":"Prodrugs - recent approvals and a glimpse of the pipeline","volume":"109","author":"Rautio","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib188","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.tips.2020.10.002","article-title":"A\u00a0novel small molecule targets NKCC1 to restore synaptic inhibition","volume":"41","author":"Raveendran","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib189","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/16697","article-title":"The K+\/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation","volume":"397","author":"Rivera","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108910_bib190","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1083\/jcb.200209011","article-title":"BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion","volume":"159","author":"Rivera","year":"2002","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib191","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1074248413497257","article-title":"Diuretics: a review and update","volume":"19","author":"Roush","year":"2014","journal-title":"J.\u00a0Cardiovasc. Pharmacol. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108910_bib192","series-title":"Informatics in Medicine Unlocked (IMU) in Press","article-title":"In silico identification of potential inhibitors with higher potency than bumetanide targeting NKCC1: an important ion cotransporter to treat neurological disorders","author":"Roy","year":"2021"},{"key":"10.1016\/j.neuropharm.2021.108910_bib193","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.02.006","article-title":"Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain","volume":"117","author":"R\u00f6mermann","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108910_bib194","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1152\/physrev.2000.80.1.211","article-title":"Sodium-potassium-chloride cotransport","volume":"80","author":"Russell","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108910_bib195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-94-007-7359-2_14","article-title":"Carbonic anhydrases and brain pH in the control of neuronal excitability","volume":"75","author":"Ruusuvuori","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib196","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/00498254.2017.1328148","article-title":"Efflux proteins at the blood-brain barrier: review and bioinformatics analysis","volume":"48","author":"Saidijam","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1016\/j.neuropharm.2021.108910_bib197","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.chempr.2020.06.017","article-title":"Discovery of a small molecule drug candidate for selective NKCC1 inhibition in brain disorders","volume":"6","author":"Savardi","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.neuropharm.2021.108910_bib198","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.tips.2021.09.005","article-title":"Pharmacological tools to target NKCC1 in brain disorders","volume":"42","author":"Savardi","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib199","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060834","article-title":"Expression and function of organic anion transporting polypeptides in the human brain: physiological and pharmacological implications","volume":"13","author":"Sch\u00e4fer","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuropharm.2021.108910_bib200","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF00587857","article-title":"Effect of \"high ceiling\" diuretics on active salt transport in the cortical thick ascending limb of Henle's loop of rabbit kidney. Correlation of chemical structure and inhibitory potency","volume":"396","author":"Schlatter","year":"1983","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2021.108910_bib201","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neubiorev.2018.05.001","article-title":"Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions","volume":"90","author":"Schulte","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2021.108910_bib202","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/j.1552-4604.1981.tb05664.x","article-title":"Metabolism of bumetanide","volume":"21","author":"Schwartz","year":"1981","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib203","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0920-1211(98)00058-8","article-title":"Osmolarity, ionic flux, and changes in brain excitability","volume":"32","author":"Schwartzkroin","year":"1998","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108910_bib204","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1093\/cercor\/bhv218","article-title":"Developmental expression patterns of KCC2 and functionally associated molecules in the human brain","volume":"26","author":"Sedmak","year":"2016","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2021.108910_bib205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cmet.2017.01.007","article-title":"WNK kinase signaling in ion homeostasis and human disease","volume":"25","author":"Shekarabi","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib206","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3171\/2009.11.JNS081052","article-title":"Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1\/TRPM4","volume":"113","author":"Simard","year":"2010","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.neuropharm.2021.108910_bib207","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1523\/JNEUROSCI.0378-05.2005","article-title":"Depolarizing GABA acts on intrinsically bursting pyramidal neurons to drive giant depolarizing potentials in the immature hippocampus","volume":"25","author":"Sipil\u00e4","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib208","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1113\/jphysiol.2006.107086","article-title":"The cation-chloride cotransporter NKCC1 promotes sharp waves in the neonatal rat hippocampus","volume":"573","author":"Sipil\u00e4","year":"2006","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib209","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1523\/JNEUROSCI.0443-09.2009","article-title":"Compensatory enhancement of intrinsic spiking upon NKCC1 disruption in neonatal hippocampus","volume":"29","author":"Sipil\u00e4","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib210","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/epi.13270","article-title":"Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus","volume":"57","author":"Sivakumaran","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib211","doi-asserted-by":"crossref","first-page":"17308","DOI":"10.1074\/jbc.M112.356014","article-title":"Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1)","volume":"287","author":"Somasekharan","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib212","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/glia.23699","article-title":"Roles of glial ion transporters in brain diseases","volume":"68","author":"Song","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2021.108910_bib213","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ana.25959","article-title":"A pilot randomized, controlled,double-blind trial of bumetanide to treat neonatal seizures","volume":"89","author":"Soul","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib214","doi-asserted-by":"crossref","first-page":"E10819","DOI":"10.1073\/pnas.1717337114","article-title":"Vasopressin excites interneurons to suppress hippocampal network activity across a broad span of brain maturity at birth","volume":"114","author":"Spoljaric","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2021.108910_bib215","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.celrep.2019.01.011","article-title":"KCC2-Mediated Cl(-) extrusion modulates spontaneous hippocampal network events in perinatal rats and mice","volume":"26","author":"Spoljaric","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2021.108910_bib216","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10803-011-1214-0","article-title":"Enhanced cortisol response to stress in children in autism","volume":"42","author":"Spratt","year":"2012","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2021.108910_bib217","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jaac.2020.07.888","article-title":"Bumetanide for core symptoms of autism spectrum disorder (BAMBI): a single center, double-blinded, participant-randomized, placebo-controlled, phase-2 superiority trial","volume":"60","author":"Sprengers","year":"2021","journal-title":"J.\u00a0Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108910_bib218","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2016.07.009","article-title":"Activation of GABA(A) receptors controls mesiotemporal lobe epilepsy despite changes in chloride transporters expression: in\u00a0vivo and in silico approach","volume":"284","author":"Stamboulian-Platel","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib220","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci. (Lond)"},{"issue":"D1","key":"10.1016\/j.neuropharm.2021.108910_bib3a","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2021.108910_bib221","series-title":"Experimental and Real-World Evidence Supporting the Computational Repurposing of Bumetanide for APOE4-Related Alzheimer's Disease","author":"Taubes","year":"2021"},{"key":"10.1016\/j.neuropharm.2021.108910_bib222","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1039\/b800767e","article-title":"Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?","volume":"6","author":"Temperini","year":"2008","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib223","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2215-0366(16)30376-5","article-title":"Neurodevelopmental disorders","volume":"4","author":"Thapar","year":"2017","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.neuropharm.2021.108910_bib224","series-title":"Hydrolytic Biotransformation of the Bumetanide Ester Prodrug DIMAEB to Bumetanide by Esterases in Neonatal Human and Rat Serum and Neonatal Rat Brain \u2013 A New Treatment Strategy for Neonatal Seizures?","author":"Theilmann","year":"2020"},{"key":"10.1016\/j.neuropharm.2021.108910_bib225","article-title":"Microglial NKCC1 shapes microglial phenotype, cerebral inflammatory responses and brain injury","author":"T\u00f3th","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.neuropharm.2021.108910_bib226","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.24124","article-title":"A\u00a0novel prodrug-based strategy to increase effects of bumetanide in epilepsy","volume":"75","author":"T\u00f6llner","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib227","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2014.10.056","article-title":"Bumetanide is not capable of terminating status epilepticus but enhances phenobarbital efficacy in different rat models","volume":"746","author":"T\u00f6llner","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib228","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2014.11.019","article-title":"The organic anion transport inhibitor probenecid increases brain concentrations of the NKCC1 inhibitor bumetanide","volume":"746","author":"T\u00f6llner","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib229","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/ejn.12424","article-title":"Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy","volume":"39","author":"T\u00f6pfer","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib230","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","article-title":"The inflammatory reflex","volume":"420","author":"Tracey","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2021.108910_bib232","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13229-020-00335-4","article-title":"Effects of bumetanide on neurodevelopmental impairments in patients with tuberous sclerosis complex: an open-label pilot study","volume":"11","author":"van Andel","year":"2020","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2021.108910_bib233","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2472555218799713","article-title":"Screening strategies and methods for better off-target liability prediction and identification of small-molecule pharmaceuticals","volume":"24","author":"Van Vleet","year":"2019","journal-title":"SLAS. Discov."},{"key":"10.1016\/j.neuropharm.2021.108910_bib234","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051603","article-title":"Regulation of AQP4 in the central nervous system","volume":"21","author":"Vandebroek","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib235","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1460-9568.2005.04459.x","article-title":"Slow endogenous activity transients and developmental expression of K+-Cl- cotransporter 2 in the immature human cortex","volume":"22","author":"Vanhatalo","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib236","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","article-title":"Neuroglial activation and neuroinflammation in the brain of patients with autism","volume":"57","author":"Vargas","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib237","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/abio.2001.5398","article-title":"Quantitation of Na+-K+-2Cl- cotransport splice variants in human tissues using kinetic polymerase chain reaction","volume":"298","author":"Vibat","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2021.108910_bib238","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2174\/13816128113199990462","article-title":"Role of monocarboxylate transporters in drug delivery to the brain","volume":"20","author":"Vijay","year":"2014","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuropharm.2021.108910_bib239","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122607","article-title":"NKCC1, an elusive molecular target in brain development: making sense of the existing data","volume":"9","author":"Virtanen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2021.108910_bib240","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tins.2021.01.004","article-title":"The multifaceted roles of KCC2 in cortical development","volume":"44","author":"Virtanen","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib241","doi-asserted-by":"crossref","first-page":"C316","DOI":"10.1152\/ajpcell.00517.2010","article-title":"Ischemia-induced stimulation of Na-K-Cl cotransport in cerebral microvascular endothelial cells involves AMP kinase","volume":"301","author":"Wallace","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib242","series-title":"Preparation of Bumetanide, Furosemide, Piretanide, Azosemide, and Torsemide Analogs and Therapeutic Compositions Containing Same for Treating Disorders Involving the Na+K+Cl- Cotransporter and GABAA Receptors","author":"Wanaski","year":"2010"},{"key":"10.1016\/j.neuropharm.2021.108910_bib243","series-title":"Arylsulfonamide Derivatives as Sodium-Potassium-Chloride Cotransporter Inhibitors and Their Preparation, Compositions, and Methods of Use","author":"Wanaski","year":"2012"},{"key":"10.1016\/j.neuropharm.2021.108910_bib244","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00429-016-1292-z","article-title":"NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility","volume":"222","author":"Wang","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2021.108910_bib245","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2014.11.031","article-title":"In\u00a0vivo effects of bumetanide at brain concentrations incompatible with NKCC1 inhibition on newborn DGC structure and spontaneous EEG seizures following hypoxia-induced neonatal seizures","volume":"286","author":"Wang","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2021.108910_bib246","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2165\/00003495-198428050-00003","article-title":"Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use","volume":"28","author":"Ward","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2021.108910_bib247","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1345\/aph.1M177","article-title":"A\u00a0comprehensive review of the loop diuretics: should furosemide be first line?","volume":"43","author":"Wargo","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neuropharm.2021.108910_bib248","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2016.1143544","article-title":"Heterogeneity of the blood-brain barrier","volume":"4","author":"Wilhelm","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.neuropharm.2021.108910_bib249","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1073\/pnas.91.6.2201","article-title":"Molecular cloning and functional expression of the bumetanide-sensitive Na-K-Cl cotransporter","volume":"91","author":"Xu","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2021.108910_bib4a","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1038\/s41467-021-25488-5","article-title":"Oligodendrocytic Na+-K+-Cl\u2013 co-transporter 1activity facilitates axonal conduction and restoresplasticity in the adult mouse brain","volume":"12","author":"Yamazaki","year":"2021","journal-title":"Nature Comm."},{"key":"10.1016\/j.neuropharm.2021.108910_bib252","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/s41467-020-14790-3","article-title":"Structure of the human cation-chloride cotransporter NKCC1 determined by single-particle electron cryo-microscopy","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108910_bib253","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000335127","article-title":"GPR35 is a target of the loop diuretic drugs bumetanide and furosemide","volume":"89","author":"Yang","year":"2012","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2021.108910_bib254","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","article-title":"Molecular architecture of the mouse nervous system","volume":"174","author":"Zeisel","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2021.108910_bib255","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41467-019-13851-6","article-title":"Modulation of brain cation-Cl(-) cotransport via the SPAK kinase inhibitor ZT-1a","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2021.108910_bib256","article-title":"Staurosporine and NEM mainly impair WNK-SPAK\/OSR1 mediated phosphorylation of KCC2 and NKCC1","volume":"15","author":"Zhang","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2021.108910_bib257","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12868-016-0295-2","article-title":"Astaxanthin alleviates cerebral edema by modulating NKCC1 and AQP4 expression after traumatic brain injury in mice","volume":"17","author":"Zhang","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108910_bib258","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s42003-021-01750-w","article-title":"The structural basis of function and regulation of neuronal cotransporters NKCC1 and KCC2","volume":"4","author":"Zhang","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.neuropharm.2021.108910_bib259","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaac.2020.03.007","article-title":"Meta-analysis: pharmacologic treatment of restricted and repetitive behaviors in autism spectrum disorders","volume":"60","author":"Zhou","year":"2021","journal-title":"J.\u00a0Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2021.108910_bib260","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.trsl.2011.04.003","article-title":"Cellular localization of NKCC2 and its possible role in the Cl- absorption in the rat and human distal colonic epithelia","volume":"158","author":"Zhu","year":"2011","journal-title":"Transl. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821004676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821004676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:19:09Z","timestamp":1758439149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821004676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":250,"alternative-id":["S0028390821004676"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108910","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNS pharmacology of NKCC1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108910"}}